Get your labs checked
At the moment, some medications can collaborate in the treatment of MASLD, some of them approved for the treatment of comorbidities such as GLP-1 agonists indicated for the treatment of T2DM or obesity, but also with benefit in the MASH treatment (9, 10)
Glycine helps buffer that stress by supporting the cellular processes that keep your energy production running efficiently
Comparing Supplement Claims to Semaglutide Clinical Evidence Semaglutide demonstrated 15-17% average weight loss in STEP trials, with some participants losing over 20% of baseline body weight
The truth is more nuanced: GLP-1 medications can be part of a long-term care plan, but ongoing success depends on understanding how appetite, metabolism, and daily habits work together
Some people may also have vomiting, Diarrhea, or stomach pain